COMMITMENTS AND CONTINGENCIES (Details Narrative) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
|
Sep. 30, 2022
USD ($)
|
Sep. 30, 2022
USD ($)
|
May 26, 2022
USD ($)
|
Aug. 26, 2021
ft²
|
|
| Commitments and Contingencies Disclosure [Abstract] | ||||
| Sublease Area | ft² | 12,112 | |||
| Sublease Area Total | ft² | 30,023 | |||
| Sublease Agreement Description | Effective August 26, 2021, the Company entered into a sublease agreement with a third party to sublease 12,112 square feet of the 30,023 square feet currently being leased under one of its two existing lease agreements. The sublease commenced on October 1, 2021 and ends October 31, 2026. The Company notes sublease income of $55,133 and $165,398 for the three and nine months ended September 30, 2022, respectively was recognized and offset against rent expense. | |||
| Subleases Income | $ | $ 55,133 | $ 165,398 | ||
| Settlement Of disputes with Venn Therapeutics, LLC | $ | $ 5,000,000 |